Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender WomenLinda‐Gail Bekker, Flavia Matovu Kiweewa, Moupali Das et al.|New England Journal of Medicine|2024Cited by 471
SARS-CoV-2 Variant is Strongly Associated with Peak Viral Load and Shedding Duration with Minimal Impact from Host Factors: Results from the CoVPN 5001 StudyWilliam O. Hahn, Ollivier Hyrien, Nicole Espy et al.|SSRN Electronic Journal|2024Cited by 0
Viral variant but not host factors associate with SARS-CoV-2 viral kineticsWilliam O. Hahn, Ollivier Hyrien, Leigh H. Fisher et al.|Communications Medicine|2026Cited by 0
Viral variant but not host factors associate with SARS-CoV-2 viral kineticsLynda Stranix‐Chibanda, Carole L. Wallis, Maphoshane Nchabeleng et al.|UNC Libraries|2026Cited by 0